The Treatment of Antibody-Mediated Rejection in Kidney Transplantation-Reference-Cited by-同舟云学术

The Treatment of Antibody-Mediated Rejection in Kidney Transplantation

Published:2018-04 Issue:4 Volume:102 Page:557-568
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Wan Susan S.,Ying Tracey D.,Wyburn Kate,Roberts Darren M.,Wyld Melanie,Chadban Steven J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference43 articles.

1. The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology;Loupy;Am J Transplant,2017

2. Diagnosis and management of antibody-mediated rejection: current status and novel approaches;Djamali;Am J Transplant,2014

3. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions;Haas;Am J Transplant,2014

4. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients.;Kidney;Am J Transplant,2009

5. The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review;Roberts;Transplantation,2012

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential effects of calcineurin inhibitors on plasma cells: Potential therapy for antibody- mediated rejection;2024-09-12

2. Coronavirus Disease 2019 in Kidney Transplantation – A 2024 Update;Advances in Kidney Disease and Health;2024-09

3. Interchain disulfide engineering enables the efficient production of functional HLA-DQ-Fc fusion proteins;Journal of Biological Chemistry;2024-09

4. Chimeric HLA antibody receptor T cell therapy for humoral transplant rejection;Nephrology Dialysis Transplantation;2024-07-18

5. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept;Clinical Immunology;2024-07